Latest Chairman and Chief Executive Officer Stories
BERWYN, Pa., Nov. 6, 2014 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced two promotions within its senior management team. Thomas C. Marecic and Ronald J.
Brings Together Two Industry Leaders with Greater Scale, Operating Efficiencies and End Market Diversification TEMPE, Ariz., and NORTH BILLERICA, Mass., Oct.
BEIJING, Aug. 20, 2014 /PRNewswire/ -- AirMedia Group Inc.
Company Reports Second Quarter 2014 Total Revenues of $291 Million, Driven by Strong Sales of Xyrem, Erwinaze and Defitelio DUBLIN, Aug.
-- AMPTEK, Inc. Broadens AMETEK's Materials Analysis Capabilities -- BERWYN, Pa., Aug. 5, 2014 /PRNewswire/ -- AMETEK, Inc.
HAMPTON, N.J., July 1, 2014 /PRNewswire/ -- Bellerophon Therapeutics, LLC, a clinical stage biotherapeutics company, leveraging its proprietary drug-device technology platform for the development
NEW YORK, June 16, 2014 /PRNewswire/ -- (Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr.
Distinguished healthcare leaders Leslie V. Norwalk and Dr. Jacque J.
- The act of sweetening by admixture of some saccharine substance.